Tilray Brands experienced a significant drop in stock value, plummeting by -15.4% pre-market, following a report of a wider-than-expected loss and missed revenue targets. The cannabis firm reported a US$105-million loss in the third quarter, despite a nearly 30% increase in net revenue. The stock plummeted as much as 19% in intraday trading, marking its most substantial drop since May 26. This downturn was attributed to weak guidance and concerns over the company's cash flow, suggesting potential issues with its going concern. Criticism has been directed at CEO Irwin Simon for not delivering a meaningful quarter since his tenure began, with warnings of further dilution and financial strain for the company.